The Weekly Close: Tech Slide Mars Weekly Stock Market Recap
This week's stock market recap: Nasdaq falls 1.72%, Dow gains 0.5%, Treasury yields drop and Comfort Systems leads a volatile week of swings.
Markets
Delayed · 01:07 UK
Financial News
Martin Holloway spent the better part of two decades on bank trading floors in the City before he started filing copy. He read Economics at a redbrick university, joined a graduate scheme at one of the UK clearers in the late 1990s, and moved across to fixed income early in his career. The bulk of his time was on macro desks at European banks, running short-end and cross-asset positions through the 2008 crisis and the long grind of the post-crisis rates regime. He stepped off the desk toward the end of the last decade, did a stint consulting on the buy side, and started writing in 2020. He covers the bits of the City he actually knows: rates, FX, UK banks, gilt issuance, and the corporate news that moves them. He has a working theory about why nobody on the sell side saw the 2022 gilt crisis coming, and is happy to share it at moderate length. Martin lives in the South East with his family. He reads the FT in the morning out of habit rather than affection, and treats most market commentary as marketing collateral written by people who have never held risk overnight.
Covers
61–70 of 690
This week's stock market recap: Nasdaq falls 1.72%, Dow gains 0.5%, Treasury yields drop and Comfort Systems leads a volatile week of swings.
Moderna cancer vaccine data confirms a 42% cut in melanoma recurrence risk, but an ESMO embargo breach triggered wild swings in MRNA shares.
SLB's third-quarter 2026 results show record revenue of $9.45bn, but GAAP net income fell as margins narrowed year-on-year.
Bloom Energy Q3 earnings beat forecasts and lifted guidance, but shares fell further after the 22 October report, extending a steep October slide.
P&G earnings beat forecasts as fiscal Q1 sales rose 4% to $23.28bn, with laundry and home care leading growth.
A melanoma vaccine data leak wiped $24bn off Moderna before its Madrid presentation, despite a statistically strong Phase 3 result.
Northern Trust Q3 earnings rose sharply, with net income up 40% to $642.9m and EPS of $3.40, beating Street estimates.
CSX third quarter results show record $4.02bn revenue and $1.05bn net earnings, beating forecasts as shares jump nearly 4%.
Texas Instruments earnings beat forecasts in Q3 2026, with EPS of $2.62 and revenue of $6.06bn topping Wall Street estimates.
Crown Castle's Q3 FFO beat drew headlines, but shares fell and no SEC filing yet backs the numbers. Here's what the record shows.
Page 7 of 69